// App-Quantinova.ai

246 : OPTIMIZATION OF SURVEILLANCE INTERVALS AFTER SUCCESSFUL RADIOFREQUENCY ABLATION THERAPY FOR DYSPLASTIC BARRETT'S ESOPHAGUS: RESULTS OF AN INTERNATIONAL MULTICENTER COHORT STUDY

Researchers

Presenter

  • Allon Kahn

Principal Investigators

  • Julia E. Crook

  • Sarmed S. Sami

  • Diana L. Snyder

  • Jacobo Ortiz Fernndez-Sordo

  • Wei Keith Tan

  • Ross Dierkhising

  • Michele L. Johnson

  • Ramona Lansing

  • Kenneth K. Wang

  • Krish Ragunath

  • Massimiliano Di Pietro

  • Herbert C. Wolfsen

  • Francisco C. Ramirez

  • David E. Fleischer

  • Cadman L. Leggett

  • Prasad G. Iyer

Medical Centers

  • Mayo Clinic, Jacksonville, FL

  • Kings College London, London, United Kingdom

  • NIHR Nottingham Digestive Diseases Biomedical Research Unit, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK

  • MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom

  • Mayo Clinic, Rochester, MN

  • Mayo Clinic, Scottsdale, AZ

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • High grade dysplasia

  • Barrett's esophagus

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved